182 related articles for article (PubMed ID: 11497230)
1. Recombinant human thrombopoietin in myelosuppressive chemotherapy.
Vadhan-Raj S
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):35-8. PubMed ID: 11497230
[TBL] [Abstract][Full Text] [Related]
2. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
Vadhan-Raj S
Semin Hematol; 2000 Apr; 37(2 Suppl 4):28-34. PubMed ID: 10831286
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
5. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
6. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
Angiolillo AL; Davenport V; Bonilla MA; van de Ven C; Ayello J; Militano O; Miller LL; Krailo M; Reaman G; Cairo MS;
Clin Cancer Res; 2005 Apr; 11(7):2644-50. PubMed ID: 15814645
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
[TBL] [Abstract][Full Text] [Related]
8. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
[TBL] [Abstract][Full Text] [Related]
9. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
11. The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Kulczyk ST; Cairo MS
Br J Haematol; 1998 Aug; 102(3):775-82. PubMed ID: 9722306
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.
Akahori H; Shibuya K; Obuchi M; Nishizawa Y; Tsuji A; Kabaya K; Kusaka M; Ohashi H; Tsumura H; Kato T; Miyazaki H
Br J Haematol; 1996 Sep; 94(4):722-8. PubMed ID: 8826901
[TBL] [Abstract][Full Text] [Related]
13. [Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Cheng BJ; Lu S; Jian H; Zhou Z; Chen ZW; Ye XY
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):395-9. PubMed ID: 21875475
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
Li Q; Ye M; Xiao W; Zhu J; Zhang S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
[TBL] [Abstract][Full Text] [Related]
15. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Dai XF; Yu J; Liu L; Wu G
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human thrombopoietin: clinical experience and in vivo biology.
Vadhan-Raj S
Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
[TBL] [Abstract][Full Text] [Related]
17. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.
Fanucchi M; Glaspy J; Crawford J; Garst J; Figlin R; Sheridan W; Menchaca D; Tomita D; Ozer H; Harker L
N Engl J Med; 1997 Feb; 336(6):404-9. PubMed ID: 9010146
[TBL] [Abstract][Full Text] [Related]
18. [Clinical tolerance test of recombinant human thrombopoietin].
Zhao Y; Jiang J; Jiao L
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
[TBL] [Abstract][Full Text] [Related]
19. Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy.
Yuan SM
Pak J Pharm Sci; 2015 Sep; 28(5):1793-6. PubMed ID: 26408899
[TBL] [Abstract][Full Text] [Related]
20. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]